Search

Eric Douglas Wieben

from Rochester, MN
Age ~74
Get Report
Also known as:
Eric D Wieben, Wieben D Eric, Eric D Weiben, Eric D Manzanares, Kristin Wieben, Kathleen Wieben
Phone and address:
1308 Northern Heights Dr NE, Rochester, MN 55906
(507) 281-2852
Related to:
Tracey J Shea, 38Tom FosterShea FosterPaul M Stewart, 69
Connected to:
Barbara J Wieben, 65Danyel Wiebenga, 48Jesse J Wiebenga, 35Paul Wiebenga, 77Peter S Wiebens, 52Chris Wieber, 54Cory E Wieber, 34Frank J Wieber, 92James S Wieber, 52John A Wieber, 91

Eric Wieben Phones & Addresses

  • 1308 Northern Heights Dr NE, Rochester, MN 55906 (507) 281-2852
  • Bainbridge Island, WA
  • Framingham, MA

Resumes

Resumes

Eric Wieben Photo 1

Director, Genomics Research At Mayo Clinic

View page
Position:
Director, Genomics Research at Mayo Clinic
Location:
Rochester, Minnesota Area
Industry:
Research
Work:
Mayo Clinic
Director, Genomics Research
Education:
Yale University 1973 - 1979
AIS 1967 - 1970

Publications

Us Patents

Sulfotransferase Sequence Variants

View page
US Patent:
7026163, Apr 11, 2006
Filed:
Feb 23, 2001
Appl. No.:
09/792695
Inventors:
Robert R. Freimuth - Rochester MN, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12N 15/11
C12N 15/54
C12N 9/10
C07H 21/04
US Classification:
4353201, 536 232, 536 2431, 435193
Abstract:
Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to thyroid disease or cancer also are described.

Sulfotransferase Sult2A1 Sequence Variants

View page
US Patent:
7056731, Jun 6, 2006
Filed:
Jun 21, 2002
Appl. No.:
10/177570
Inventors:
Bianca A. Thomae - Rochester MN, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12N 15/11
C12N 15/54
C12N 9/10
US Classification:
4353201, 536 232, 536 2431, 435193
Abstract:
Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to a heart condition or cancer also are described.

3′-Phosphoadenosine-5′-Phosphosulfate Synthetase 1 (Papss1) Sequence Variants

View page
US Patent:
7067311, Jun 27, 2006
Filed:
Nov 14, 2002
Appl. No.:
10/294229
Inventors:
Zhenhua Xu - Bridgewater NJ, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12N 15/12
US Classification:
4353201, 536 231, 536 235
Abstract:
Isolated PAPSS1 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as PAPSS1 allozymes. Methods for determining if a mammal is predisposed to joint disease or cancer also are described.

3′-Phosphoadenosine -5′-Phosphosulfate Synthetase 2 (Papss2) Sequence Variants

View page
US Patent:
7186551, Mar 6, 2007
Filed:
Nov 14, 2002
Appl. No.:
10/294397
Inventors:
Zhenhua Xu - Bridgewater NJ, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12N 15/11
C12N 15/54
C12N 15/63
C12N 9/10
C12N 9/12
US Classification:
4353201, 536 232, 536 243, 536 2431, 536 231, 435193, 435194
Abstract:
Isolated PAPSS2 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as PAPSS2 allozymes. Methods for determining if a mammal is predisposed to joint disease or cancer also are described.

Arsenic Methyltransferase Sequence Variants

View page
US Patent:
7250290, Jul 31, 2007
Filed:
Apr 15, 2004
Appl. No.:
10/824828
Inventors:
Bianca A. Thomae - Bay Village OH, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Thomas C. Wood - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12N 9/10
C12N 15/00
C07H 21/04
US Classification:
4353201, 536 232, 536 243, 435193
Abstract:
Isolated ASMT nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as ASMT allozymes. Methods for determining if a mammal is at risk for toxicity from acute or chronic arsenic exposure also are described.

3′-Phosphoadenosine-5′-Phosphosulfate Synthetase 1 (Papss1) Sequence Variants

View page
US Patent:
7288399, Oct 30, 2007
Filed:
May 2, 2006
Appl. No.:
11/416116
Inventors:
Zhenhua Xu - Bridgewater NJ, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12N 9/12
US Classification:
435194
Abstract:
Isolated PAPSS1 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as PAPSS1 allozymes. Methods for determining if a mammal is predisposed to joint disease or cancer also are described.

Sulfotransferase 1E1 Sequence Variants

View page
US Patent:
7288641, Oct 30, 2007
Filed:
Jan 30, 2003
Appl. No.:
10/354763
Inventors:
Araba A. Adjei - Rochester MN, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Bianca A. Thomae - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07H 21/02
C07H 21/04
C12P 19/34
C12Q 1/68
US Classification:
536 231, 536 243, 435 911, 435 912, 435 6
Abstract:
Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.

Sulfotransferase 2B1 Pharmacogenetics

View page
US Patent:
7288642, Oct 30, 2007
Filed:
Nov 6, 2003
Appl. No.:
10/702981
Inventors:
Bianca A. Thomae - Bay Village OH, US
Eric D. Wieben - Rochester MN, US
Richard M. Weinshilboum - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07H 21/02
C07H 21/04
C12P 19/34
C12Q 1/68
US Classification:
536 231, 536 243, 435 911, 435 912, 435 6
Abstract:
Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as are sulfotransferase allozymes. Methods for determining the sulfonator status of a subject also are described. In addition, methods for predicting the therapeutic efficacy of a compound in a subject are described, as are methods for estimating the dose of a compound to be administered to a subject.
Control profile
Eric Douglas Wieben from Rochester, MN, age ~74 Get Report